🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the size of the benefit of an adj...
Status
Completed
Location
Medizinische Fakultät der Humboldt Universität Berlin (Charité)
Start Date
2008-10
Trial ID
NCT00707369
Treatments Being Tested
This will be a two-part study in healthy adults. Part A is a phase 1, non-r...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-05
Trial ID
NCT01848340
Treatments Being Tested
This randomized, cross over study aims to find out the benefits of deliveri...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-20
Trial ID
NCT03227445
Treatments Being Tested
This study is designed to assess the proportion of asthma subjects making c...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11
Trial ID
NCT02195284
Treatments Being Tested
The primary objective of this study is to assess the effect of umeclidinium...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-07-14
Trial ID
NCT02799784
Treatments Being Tested
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10453
Start Date
2013-01
Trial ID
NCT01772368
Treatments Being Tested
The goal of this research project is to explore the impact of the addition ...
Status
Completed
Location
Washington University School of Medicine
Start Date
2016-01-01
Trial ID
NCT02696850
Treatments Being Tested
This is a Phase IV multi-center, randomized, open-label, cross-over, placeb...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-21
Trial ID
NCT02786927
This study will be conducted to evaluate the safety and efficacy of sumatri...
Status
Terminated
Location
Phoenix Children's Hospital
Start Date
2017-11-02
Trial ID
NCT03338920
Treatments Being Tested
The primary objective is to evaluate whether DAS181 is safe in subjects wit...
Status
Completed
Location
NIH Clinical Center
Start Date
2010-07
Trial ID
NCT01113034
Treatments Being Tested